1. Home
  2. GAUZ vs CABA Comparison

GAUZ vs CABA Comparison

Compare GAUZ & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • CABA
  • Stock Information
  • Founded
  • GAUZ 2009
  • CABA 2017
  • Country
  • GAUZ Israel
  • CABA United States
  • Employees
  • GAUZ N/A
  • CABA N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAUZ Miscellaneous
  • CABA Health Care
  • Exchange
  • GAUZ Nasdaq
  • CABA Nasdaq
  • Market Cap
  • GAUZ 152.3M
  • CABA 157.4M
  • IPO Year
  • GAUZ 2024
  • CABA 2019
  • Fundamental
  • Price
  • GAUZ $5.80
  • CABA $1.71
  • Analyst Decision
  • GAUZ Strong Buy
  • CABA Strong Buy
  • Analyst Count
  • GAUZ 3
  • CABA 7
  • Target Price
  • GAUZ $14.67
  • CABA $14.43
  • AVG Volume (30 Days)
  • GAUZ 67.2K
  • CABA 3.0M
  • Earning Date
  • GAUZ 08-07-2025
  • CABA 08-07-2025
  • Dividend Yield
  • GAUZ N/A
  • CABA N/A
  • EPS Growth
  • GAUZ N/A
  • CABA N/A
  • EPS
  • GAUZ N/A
  • CABA N/A
  • Revenue
  • GAUZ $101,165,000.00
  • CABA N/A
  • Revenue This Year
  • GAUZ $28.49
  • CABA N/A
  • Revenue Next Year
  • GAUZ $47.77
  • CABA N/A
  • P/E Ratio
  • GAUZ N/A
  • CABA N/A
  • Revenue Growth
  • GAUZ 18.63
  • CABA N/A
  • 52 Week Low
  • GAUZ $5.70
  • CABA $0.99
  • 52 Week High
  • GAUZ $13.00
  • CABA $8.77
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • CABA 49.70
  • Support Level
  • GAUZ N/A
  • CABA $1.43
  • Resistance Level
  • GAUZ N/A
  • CABA $1.68
  • Average True Range (ATR)
  • GAUZ 0.00
  • CABA 0.13
  • MACD
  • GAUZ 0.00
  • CABA -0.02
  • Stochastic Oscillator
  • GAUZ 0.00
  • CABA 62.22

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: